ID   RN126_HUMAN             Reviewed;         326 AA.
AC   Q9BV68; Q9NWX1;
DT   27-SEP-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   10-MAY-2017, entry version 132.
DE   RecName: Full=E3 ubiquitin-protein ligase RNF126 {ECO:0000305};
DE            EC=2.3.2.27 {ECO:0000269|PubMed:23026136, ECO:0000269|PubMed:24981174};
DE   AltName: Full=RING finger protein 126 {ECO:0000312|HGNC:HGNC:21151};
GN   Name=RNF126 {ECO:0000312|HGNC:HGNC:21151};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [4]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-5, CLEAVAGE OF INITIATOR METHIONINE [LARGE
RP   SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, INTERACTION WITH CDKN1A,
RP   SUBCELLULAR LOCATION, UBIQUITINATION, TISSUE SPECIFICITY, AND
RP   MUTAGENESIS OF CYS-229 AND CYS-232.
RX   PubMed=23026136; DOI=10.1158/0008-5472.CAN-12-0562;
RA   Zhi X., Zhao D., Wang Z., Zhou Z., Wang C., Chen W., Liu R., Chen C.;
RT   "E3 ubiquitin ligase RNF126 promotes cancer cell proliferation by
RT   targeting the tumor suppressor p21 for ubiquitin-mediated
RT   degradation.";
RL   Cancer Res. 73:385-394(2013).
RN   [6]
RP   FUNCTION, AND INTERACTION WITH CCDC50; EGFR; FLT3 AND SCAMP3.
RX   PubMed=23418353; DOI=10.1242/jcs.116129;
RA   Smith C.J., Berry D.M., McGlade C.J.;
RT   "The E3 ubiquitin ligases RNF126 and Rabring7 regulate endosomal
RT   sorting of the epidermal growth factor receptor.";
RL   J. Cell Sci. 126:1366-1380(2013).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-5, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH AICDA.
RX   PubMed=23277564; DOI=10.1073/pnas.1214538110;
RA   Delker R.K., Zhou Y., Strikoudis A., Stebbins C.E., Papavasiliou F.N.;
RT   "Solubility-based genetic screen identifies RING finger protein 126 as
RT   an E3 ligase for activation-induced cytidine deaminase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:1029-1034(2013).
RN   [9]
RP   FUNCTION.
RX   PubMed=24275455; DOI=10.1016/j.yexcr.2013.11.013;
RA   Smith C.J., McGlade C.J.;
RT   "The ubiquitin ligase RNF126 regulates the retrograde sorting of the
RT   cation-independent mannose 6-phosphate receptor.";
RL   Exp. Cell Res. 320:219-232(2014).
RN   [10]
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, AND INTERACTION WITH BAG6.
RX   PubMed=24981174; DOI=10.1016/j.molcel.2014.05.025;
RA   Rodrigo-Brenni M.C., Gutierrez E., Hegde R.S.;
RT   "Cytosolic quality control of mislocalized proteins requires RNF126
RT   recruitment to Bag6.";
RL   Mol. Cell 55:227-237(2014).
RN   [11] {ECO:0000244|PDB:2N9O, ECO:0000244|PDB:2N9P}
RP   STRUCTURE BY NMR OF 1-40 IN COMPLEX WITH BAG6 AND ZINC, DOMAIN,
RP   INTERACTION WITH BAG6, ZINC-BINDING, AND MUTAGENESIS OF HIS-14; PHE-36
RP   AND 38-GLU-GLU-39.
RX   PubMed=27193484; DOI=10.1038/srep26433;
RA   Krysztofinska E.M., Martinez-Lumbreras S., Thapaliya A., Evans N.J.,
RA   High S., Isaacson R.L.;
RT   "Structural and functional insights into the E3 ligase, RNF126.";
RL   Sci. Rep. 6:26433-26433(2016).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase that mediates ubiquitination
CC       oF target proteins (PubMed:23277564, PubMed:24275455,
CC       PubMed:24981174). Depending on the associated E2 ligase, mediates
CC       'Lys-48'- and 'Lys-63'-linked polyubiquitination of substrates (By
CC       similarity). Part of a BAG6-dependent quality control process
CC       ensuring that proteins of the secretory pathway that are
CC       mislocalized to the cytosol are degraded by the proteasome.
CC       Probably acts by providing the ubiquitin ligase activity
CC       associated with the BAG6 complex and be responsible for
CC       ubiquitination of the hydrophobic mislocalized proteins and their
CC       targeting to the proteasome (PubMed:24981174). May also play a
CC       role in the endosomal recycling of IGF2R, the cation-independent
CC       mannose-6-phosphate receptor (PubMed:24275455). May play a role in
CC       the endosomal sorting and degradation of several membrane
CC       receptors including EGFR, FLT3, MET and CXCR4, by mediating their
CC       ubiquitination (PubMed:23418353). By ubiquitinating CDKN1A/p21 and
CC       targeting it for degradation, may also promote cell proliferation
CC       (PubMed:23026136). May monoubiquitinate AICDA (PubMed:23277564).
CC       {ECO:0000250|UniProtKB:Q91YL2, ECO:0000269|PubMed:23277564,
CC       ECO:0000269|PubMed:23418353, ECO:0000269|PubMed:24275455,
CC       ECO:0000269|PubMed:24981174, ECO:0000305|PubMed:23026136}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine. {ECO:0000269|PubMed:23026136,
CC       ECO:0000269|PubMed:24981174}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000269|PubMed:23026136, ECO:0000269|PubMed:24981174}.
CC   -!- SUBUNIT: Interacts with CCDC50, EGFR, FLT3 and SCAMP3
CC       (PubMed:23418353). Interacts with BAG6 (via ubiquitin-like
CC       domain); required for BAG6-dependent ubiquitination of proteins
CC       mislocalized to the cytosol (PubMed:24981174, PubMed:27193484).
CC       Interacts with CDKN1A (PubMed:23026136). Interacts with AICDA
CC       (PubMed:23277564). {ECO:0000269|PubMed:23026136,
CC       ECO:0000269|PubMed:23277564, ECO:0000269|PubMed:23418353,
CC       ECO:0000269|PubMed:24981174, ECO:0000269|PubMed:27193484}.
CC   -!- INTERACTION:
CC       P46379:BAG6; NbExp=4; IntAct=EBI-357322, EBI-347552;
CC       P51668:UBE2D1; NbExp=8; IntAct=EBI-357322, EBI-743540;
CC       P62837:UBE2D2; NbExp=4; IntAct=EBI-357322, EBI-347677;
CC       P61077:UBE2D3; NbExp=5; IntAct=EBI-357322, EBI-348268;
CC       Q9Y2X8:UBE2D4; NbExp=5; IntAct=EBI-357322, EBI-745527;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:23026136}.
CC       Nucleus {ECO:0000269|PubMed:23026136}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9BV68-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BV68-2; Sequence=VSP_015693, VSP_015694;
CC   -!- TISSUE SPECIFICITY: Highly expressed in liver and testis.
CC       {ECO:0000269|PubMed:23026136}.
CC   -!- DOMAIN: The C4-type zinc finger is required for interaction with
CC       BAG6. {ECO:0000269|PubMed:27193484}.
CC   -!- PTM: Ubiquitinated. May undergo autoubiquitination.
CC       {ECO:0000269|PubMed:23026136}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK000559; BAA91254.1; -; mRNA.
DR   EMBL; BC001442; AAH01442.1; -; mRNA.
DR   EMBL; BC025374; AAH25374.1; -; mRNA.
DR   CCDS; CCDS12039.1; -. [Q9BV68-2]
DR   RefSeq; NP_919442.1; NM_194460.2. [Q9BV68-2]
DR   UniGene; Hs.69554; -.
DR   PDB; 2N9O; NMR; -; A=1-40.
DR   PDB; 2N9P; NMR; -; A=1-40.
DR   PDBsum; 2N9O; -.
DR   PDBsum; 2N9P; -.
DR   ProteinModelPortal; Q9BV68; -.
DR   SMR; Q9BV68; -.
DR   BioGrid; 120790; 92.
DR   IntAct; Q9BV68; 31.
DR   MINT; MINT-1032305; -.
DR   STRING; 9606.ENSP00000292363; -.
DR   iPTMnet; Q9BV68; -.
DR   PhosphoSitePlus; Q9BV68; -.
DR   BioMuta; RNF126; -.
DR   DMDM; 74762712; -.
DR   EPD; Q9BV68; -.
DR   MaxQB; Q9BV68; -.
DR   PaxDb; Q9BV68; -.
DR   PeptideAtlas; Q9BV68; -.
DR   PRIDE; Q9BV68; -.
DR   Ensembl; ENST00000292363; ENSP00000292363; ENSG00000070423. [Q9BV68-2]
DR   GeneID; 55658; -.
DR   KEGG; hsa:55658; -.
DR   UCSC; uc010drs.4; human. [Q9BV68-1]
DR   CTD; 55658; -.
DR   GeneCards; RNF126; -.
DR   H-InvDB; HIX0014558; -.
DR   HGNC; HGNC:21151; RNF126.
DR   HPA; HPA043050; -.
DR   MIM; 615177; gene.
DR   neXtProt; NX_Q9BV68; -.
DR   OpenTargets; ENSG00000070423; -.
DR   PharmGKB; PA134876469; -.
DR   eggNOG; KOG0800; Eukaryota.
DR   eggNOG; ENOG41121N2; LUCA.
DR   GeneTree; ENSGT00530000062967; -.
DR   HOGENOM; HOG000116417; -.
DR   HOVERGEN; HBG059832; -.
DR   InParanoid; Q9BV68; -.
DR   KO; K11982; -.
DR   OMA; FCHRCSE; -.
DR   OrthoDB; EOG091G0SOO; -.
DR   PhylomeDB; Q9BV68; -.
DR   TreeFam; TF317985; -.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; RNF126; human.
DR   GenomeRNAi; 55658; -.
DR   PRO; PR:Q9BV68; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000070423; -.
DR   CleanEx; HS_RNF126; -.
DR   ExpressionAtlas; Q9BV68; baseline and differential.
DR   Genevisible; Q9BV68; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005154; F:epidermal growth factor receptor binding; IEA:Ensembl.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; IMP:UniProtKB.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:UniProtKB.
DR   GO; GO:0070936; P:protein K48-linked ubiquitination; ISS:UniProtKB.
DR   GO; GO:0070534; P:protein K63-linked ubiquitination; ISS:UniProtKB.
DR   GO; GO:0006513; P:protein monoubiquitination; IDA:UniProtKB.
DR   GO; GO:0000209; P:protein polyubiquitination; IBA:GO_Central.
DR   GO; GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IDA:UniProtKB.
DR   GO; GO:0042127; P:regulation of cell proliferation; IMP:UniProtKB.
DR   GO; GO:0042147; P:retrograde transport, endosome to Golgi; IMP:UniProtKB.
DR   GO; GO:0071629; P:ubiquitin-dependent catabolism of misfolded proteins by cytoplasm-associated proteasome; IMP:UniProtKB.
DR   GO; GO:0043162; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; IMP:UniProtKB.
DR   CDD; cd00162; RING; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   Pfam; PF13639; zf-RING_2; 1.
DR   SMART; SM00184; RING; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Cytoplasm; Metal-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transferase; Ubl conjugation;
KW   Ubl conjugation pathway; Zinc; Zinc-finger.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:20068231}.
FT   CHAIN         2    326       E3 ubiquitin-protein ligase RNF126.
FT                                /FTId=PRO_0000056093.
FT   ZN_FING      13     32       C4-type. {ECO:0000269|PubMed:27193484}.
FT   ZN_FING     229    270       RING-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00175}.
FT   REGION        5    100       Required for interaction with BAG6.
FT                                {ECO:0000269|PubMed:24981174}.
FT   REGION      200    304       Sufficient for interaction with AICDA.
FT                                {ECO:0000269|PubMed:23277564}.
FT   COMPBIAS    289    303       Ser-rich.
FT   METAL        13     13       Zinc. {ECO:0000244|PDB:2N9O,
FT                                ECO:0000269|PubMed:27193484}.
FT   METAL        16     16       Zinc. {ECO:0000244|PDB:2N9O,
FT                                ECO:0000269|PubMed:27193484}.
FT   METAL        29     29       Zinc. {ECO:0000244|PDB:2N9O,
FT                                ECO:0000269|PubMed:27193484}.
FT   METAL        32     32       Zinc. {ECO:0000244|PDB:2N9O,
FT                                ECO:0000269|PubMed:27193484}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES       5      5       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     309    311       WSP -> SNS (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_015693.
FT   VAR_SEQ     312    326       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_015694.
FT   VARIANT      68     68       V -> M (in dbSNP:rs2285751).
FT                                /FTId=VAR_057217.
FT   MUTAGEN      14     14       H->A: Impaired interaction with BAG6.
FT                                {ECO:0000269|PubMed:27193484}.
FT   MUTAGEN      36     36       F->A: Impaired interaction with BAG6.
FT                                {ECO:0000269|PubMed:27193484}.
FT   MUTAGEN      38     39       EE->RR: Impaired interaction with BAG6.
FT                                {ECO:0000269|PubMed:27193484}.
FT   MUTAGEN     229    229       C->A: Loss of E3 ligase activity; when
FT                                associated with A-232.
FT                                {ECO:0000269|PubMed:23026136}.
FT   MUTAGEN     232    232       C->A: Loss of E3 ligase activity; when
FT                                associated with A-229.
FT                                {ECO:0000269|PubMed:23026136}.
FT   STRAND       11     13       {ECO:0000244|PDB:2N9O}.
FT   TURN         14     17       {ECO:0000244|PDB:2N9O}.
FT   STRAND       18     20       {ECO:0000244|PDB:2N9O}.
FT   TURN         24     26       {ECO:0000244|PDB:2N9O}.
FT   TURN         30     32       {ECO:0000244|PDB:2N9O}.
FT   STRAND       37     39       {ECO:0000244|PDB:2N9O}.
SQ   SEQUENCE   326 AA;  35585 MW;  D422FFB090362F46 CRC64;
     MAEASPHPGR YFCHCCSVEI VPRLPDYICP RCESGFIEEL PEETRSTENG SAPSTAPTDQ
     SRPPLEHVDQ HLFTLPQGYG QFAFGIFDDS FEIPTFPPGA QADDGRDPES RRERDHPSRH
     RYGARQPRAR LTTRRATGRH EGVPTLEGII QQLVNGIITP ATIPSLGPWG VLHSNPMDYA
     WGANGLDAII TQLLNQFENT GPPPADKEKI QALPTVPVTE EHVGSGLECP VCKDDYALGE
     RVRQLPCNHL FHDGCIVPWL EQHDSCPVCR KSLTGQNTAT NPPGLTGVSF SSSSSSSSSS
     SPSNENATWS PLGRPQPPRP LSNLTL
//
